Literature DB >> 10668454

The regulation of cerebral blood flow during intravenous cocaine administration in cocaine abusers.

R I Herning1, W Better, R Nelson, D Gorelick, J L Cadet.   

Abstract

Cocaine abuse is associated with heightened risk of life-threatening neurological complications such as strokes, seizures, and transient ischemic attacks. We used transcranial Doppler (TCD) sonography, a continuous measure of cerebral blood flow velocity, to better understand the changes in cerebral hemodynamics produced by cocaine administration, which may lead to an increased risk for stroke in cocaine abusers. Heart rate and blood pressure were also measured. Blood flow velocity of seven cocaine abusers was studied during placebo, 10-, 25-, and 50-mg intravenous (i.v.) injections of cocaine. A significant increase in mean and systolic velocity which lasted for about two minutes was observed with all doses of cocaine, with no change in the placebo condition. This increase in systolic velocity indicates that cocaine produces an immediate and brief period of vasoconstriction in large arteries of the brain. The present results elucidate the time course of cocaine's acute cerebrovascular effects and provide a better understanding of etiology of cocaine-related stroke and transient ischemic attacks.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668454     DOI: 10.1111/j.1749-6632.1999.tb08030.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  2 in total

Review 1.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

2.  Cocaine addicted rats show reduced neural activity as revealed by manganese-enhanced MRI.

Authors:  Nazzareno Cannella; Alejandro Cosa-Linan; Tatiane Takahashi; Wolfgang Weber-Fahr; Rainer Spanagel
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.